| Name | Title | Contact Details |
|---|
P And S Masonry Inc is a Hamilton, TX-based company in the Business Services sector.
Admail.net is a Aurora, OH-based company in the Business Services sector.
QSound Labs, Inc. is a Calgary, AB-based company in the Business Services sector.
As a global investment manager, we help institutions, intermediaries and individuals meet their goals, fulfil their ambitions, and prepare for the future. But as the world changes, so do our clients needs. Thats why we have a long history of adapting to suit the times and keeping our focus on what matters most to our clients. Doing this takes experience and expertise. We bring together people and data to spot the trends that will shape the future. This provides a unique perspective which allows us to always invest with conviction. We are responsible for £449.4 billion (€508.2 billion/$593.3 billion) of assets for our clients who trust us to deliver sustainable returns. We remain determined to build future prosperity for them, and for all of society. Today, we have 4,900 people across six continents who focus on doing just this. We are a global business thats managed locally. This allows us to always keep our clients needs at the heart of everything we do. For over 200 years and more than seven generations we have grown and developed our expertise in tandem with our clients needs and interests. Explore our interactive timeline to see how we have been shaping financial futures since our very beginnings.
Ultima Genomics is unleashing the power of genomics at scale. Our mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biologys complexity and dynamic change—and a further need to challenge conventional next-generation sequencing technologies. Ultimas revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information. The new sequencing architecture was designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information and catalyze the next phase of genomics in the 21st century.